Showing results (261-270 of 397) with videos related to
Sort By:
Pageof 40
BJU International|August 23, 2025
Staging metastatic urothelial cancer with Nectin-4 imaging using Gallium-68-N188 PET/CTMatthias Miederer, Marc Pretze, Elena Abbate, et al.Urologia Internationalis|January 20, 2020
AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPCHolger Hans Herman Erb, Peter Sparwasser, Tamara Diehl, et al.World Journal of Urology|January 8, 2024
The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature searchSemih Sarcan, Ingmar Wolff, Lukas Lusuardi, et al.Urologic Oncology|April 22, 2019
sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitroIgor Tsaur, Tanja Hüsch, Eva Jüngel, et al.Diseases of the Colon and Rectum|November 30, 2007
Prevalence of anal cytologic abnormalities in a French referral population: a prospective study with special emphasis on HIV, HPV, and smokingIsabelle Etienney, Sarra Vuong, Fady Daniel, et al.Clinical Neurology and Neurosurgery|December 22, 2023
Patient-reported symptomatology and its course in spontaneous intracranial hypotension - Beware of a chameleonChristopher Marvin Jesse, Ralph T Schär, Johannes Goldberg, et al.Brain Communications|December 31, 2024
Increased cell-free DNA in CSF and serum of hip fracture patients with deliriumVibeke Bratseth, Leiv Otto Watne, Bjørn Erik Neerland, et al.European Urology Focus|December 6, 2024
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE DataBenedikt Hoeh, Mike Wenzel, Zhe Tian, et al.Translational Oncology|December 28, 2019
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell CarcinomaPhilipp J Stenzel, Mario Schindeldecker, Katrin E Tagscherer, et al.International Journal of Molecular Sciences|December 5, 2019
Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever VaccinationLeoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.Pageof 40